General characteristics of the pathology
Amyloidosis is a systemic process. Although the causes of selective protein complex deposition in specific organs remain unknown, clinical practice demonstrates clear patterns.
Potentially, the pathological process can involve almost any organ of the human body. However, the most frequently affected are:
- Kidneys (renal failure has the greatest clinical significance).
- Heart.
- Nervous system.
- Intestines.
Etiology and classification
Modern propedeutics distinguishes several main forms of amyloidosis. The classification is based on the biochemical type of the deposited amyloid and factors that provoke its formation:
- Secondary amyloidosis (AA type). Strongly associated with chronic inflammation in the body. The main causes triggering AA amyloid synthesis include specific infections (tuberculosis, syphilis), severe purulent-inflammatory diseases (osteomyelitis, bronchiectasis), as well as autoimmune processes (rheumatoid arthritis).
- Primary amyloidosis (AL type). Occurs sporadically. In this form, the patient lacks any preceding "causative" disease that could provoke a metabolic shift.
- Transthyretin amyloidosis (ATTR type). This group combines hereditary (familial) forms of the pathology, as well as senile amyloidosis.
Clinical manifestations and renal involvement
The general clinical picture always depends on which organ predominantly accumulates amyloid. However, renal symptoms come to the forefront and determine the prognosis.
The dynamics of renal impairment development is always gradual. The pathology goes through several stages:
- Initial stage. Manifests as prolonged, moderately severe proteinuria (loss of protein in the urine).
- Advanced stage. Classic nephrotic syndrome develops, which is the main clinical marker of renal amyloidosis.
Nephrotic syndrome in amyloidosis necessarily includes:
- Massive proteinuria (leading sign).
- Hypoproteinemia (decreased blood protein level due to its losses).
- Hypercholesterolemia.
- Pronounced edema syndrome.
Principles of treatment
To date, specific therapy for amyloidosis requires further study and development.
The main vector of treatment aims to eliminate the cause: in secondary (AA) amyloidosis, maximally active treatment of the underlying disease is necessary (suppression of chronic inflammation, treatment of tuberculosis, sanitation of purulent foci). As part of medical support, it has been proven that in certain forms of the disease, the use of colchicine provides a good clinical effect.
Briefly: answers to topical questions
What are the classic clinical stages of renal amyloidosis distinguished?
Classically, four clinical stages of renal amyloidosis are distinguished:
- Latent.
- Proteinuric.
- Nephrotic.
- Azotemic.
Which diseases are the main causes of secondary AA amyloidosis development?
Secondary AA amyloidosis is associated with chronic inflammation. Sources indicate the following among causes and associations:
- tuberculosis;
- syphilis;
- suppurative-inflammatory processes: osteomyelitis, bronchiectasis, pulmonary suppuration;
- rheumatoid arthritis;
- ulcerative colitis;
- certain tumors;
- subacute infective endocarditis.
Which protein is the precursor in primary AL amyloidosis?
The precursor protein in primary AL amyloidosis is immunoglobulin light chains (Bence Jones protein). This abnormal fibrillar protein is produced by a pathological clone of plasma cells and has the property of forming insoluble extracellular aggregates.
What diagnostic method reliably confirms the diagnosis of amyloidosis (gold standard)?
The diagnosis of amyloidosis is confirmed by morphological examination of biopsy material stained with Congo red and subsequent polarizing microscopy. Under light microscopy, amyloid masses stain brick-red/orange-red, while polarized light reveals an apple-green birefringence. To confirm systemic amyloidosis, biopsy specimens of affected organs, as well as gingival, rectal mucosal, or renal tissue, may be examined.
Which stage is the terminal stage in renal amyloidosis and what condition does it lead to?
The terminal stage in the clinical progression of renal amyloidosis is the azotemic stage. The outcome of renal involvement follows this sequence: severe proteinuria → nephrotic syndrome → glomerular destruction → amyloid shrunken kidney → chronic renal failure → death from uremic syndrome.
To remember the secondary type: AA amyloidosis — Active Attack of inflammation (tuberculosis, rheumatoid arthritis, suppuration).
Class and exam questions
Which syndrome is the main clinical marker of renal amyloidosis?
Classic nephrotic syndrome. It includes massive proteinuria, hypoproteinemia, hypercholesterolemia, and marked edema.
How rapidly do symptoms develop in renal involvement?
The process develops gradually. Severe nephrotic syndrome is always preceded by a prolonged stage of moderate proteinuria.
What is the main difference between AL amyloidosis and AA amyloidosis?
AL amyloidosis (primary) occurs sporadically without an apparent cause. AA amyloidosis (secondary) is always associated with prolonged chronic inflammation in the body.
What else to study on this topic
- {'topic': 'Mechanisms of selective organ involvement (why amyloid is deposited specifically in the kidneys)'}
- {'topic': 'Clinical presentation of amyloidosis with cardiac and nervous system involvement'}
- {'topic': 'Pathogenesis of senile and hereditary ATTR amyloidosis'}
- {'topic': 'Prospects for developing new treatments for amyloidosis'}
Master the entire topic in the "Propaedeutics" course
This is a summary. The course covers everything tested in classes and exams.
- Full study guide on "Renal Amyloidosis" and 3,152 other pages for this subject
- Assignments and quizzes after every topic — just like in a colloquium
- AI tutor answers questions on the topic anytime
- 113 video lessons on the subject
Other topics in the "Urinary System" section
Prepared by WhiteCoat Pro faculty in accordance with the medical school curriculum. For educational purposes only.